歡迎來(lái)到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁(yè) > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗CDKN2AIP多克隆抗體

產(chǎn)品中心

  • 兔抗CDKN2AIP多克隆抗體

    規(guī)格:
    數(shù)量:

    購(gòu)買(mǎi)數(shù)量

    價(jià)格:
    • 品牌 : 通蔚生物
    • 目錄號(hào) : TW5651
    • 應(yīng)用 : 僅用于科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫(kù)存:35
  • 商品詳情
  • 參考文獻(xiàn)
  • 說(shuō)明書(shū)下載
  • 商品評(píng)論0
  • 相關(guān)產(chǎn)品

中文名稱(chēng):兔抗CDKN2AIP多克隆抗體

英文名稱(chēng):
Anti-CDKN2AIP rabbit polyclonal antibody

別      名: CARF

抗      原: CDKN2AIP

儲(chǔ)      存:
冷凍(-20℃)

宿      主: Rabbit

相關(guān)類(lèi)別: 一抗

反應(yīng)種屬: Human

標(biāo) 記 物: Unconjugate

克隆類(lèi)型: rabbit polyclonal

技術(shù)規(guī)格

Background:

CDKN2AIP (CDKN2A-interacting protein), also known as CARF, is a 580 amino acid protein that activates p53 via p14 ARF (alternate reading frame)-dependent and independent pathways. CDKN2AIP-dependent activation of p53, a protein that up-regulates growth arrest and apoptosis-related genes in response to stress signals, leads to an enhancement of p53 function. Expression levels of CDKN2AIP and p53 show an inverse relationship that is caused by a negative-feedback control via a proteasome-mediated degradation pathway. CDKN2AIP is expressed ubiquitously across tissue samples and, along with p14 ARF, is localized to the perinucleolar region within the nucleus.

Applications:

ELISA, IHC

Name of antibody:

CDKN2AIP

Immunogen:

Fusion protein of human CDKN2AIP

Full name:

CDKN2A interacting protein

Synonyms:

CARF

SwissProt:

Q9NXV6

ELISA Recommended dilution:

1000-5000

IHC positive control:

Human thyroid cancer

IHC Recommend dilution:

50-200